Cantargia (Cantargia AB); today announced new clinical results from two nadunolimab combination therapy trials in 54 patients. Positive signals of efficacy were documented in the key areas of ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) stock is trading higher on Monday after the company released new preclinical ...

Manur Multi Specialty Hospital successfully treats 14-year-old boy with Guillain-Barre Syndrome, AMSAN, and breathing issues.

Promising Preclinical Results Position Ketamir-2 as a Potential Breakthrough Therapy That Surpasses Current Treatments, With Results to Be ...

GenSight Biologics' lead product candidate, GS010, is in Phase III trials in Leber Hereditary Optic Neuropathy (LHON), a rare mitochondrial disease that leads to irreversible blindness in teens and ...

The complement inhibitors market is gaining momentum due to the rising recognition of the complement system's role in driving rare and chronic diseases, such as paroxysmal nocturnal hemoglobinuria ...

Two decades ago, when two genetic mutations were discovered in Asia that gave scientists a better idea of how pain sensations ...

Grace, 19, was told she had cancer just days after her 16th birthday. Following years of treatment, Grace was helped in her ...

The recall was initiated on October 10 and is ongoing. “Healthcare professionals can educate patients about alternative ...

Injury to the eye can also cause sudden vision loss, said Dr Vinit Banga, director of neurology and head of neuro ...